CliniSciences
CliniSciences is a privately held French-European distributor of reagents, instruments, and in vitro diagnostic products for immunology, cell biology, molecular biology, and oncology research, serving over 350,000 customers across 15 countries with a PhD-staffed scientific support team.
- Company typePrivate
- Founded-
- HeadquartersNanterre, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CliniSciences does
CliniSciences is a privately held European distributor of reagents, instruments, and in vitro diagnostic (IVD) products serving immunology, cell biology, and molecular biology research. Headquartered in Nanterre, France with its legal entity CliniSciences LLC registered in Miramar Beach, Florida, the company operates across 15 countries through approximately 100 employees (the majority holding PhDs in science), serving more than 350,000 customers daily. Its catalog spans FPLC columns, histological dyes, plant culture products, cell study kits, culture flasks, immunoassays, IHC detection kits, lectins, NGS products, radiochemical products, tetramers and monomers, fluorescent gel stains (NeoDye DNA, GelRed, GelGreen, SYBR), and proprietary products including CellCover, the PA-3600 automated IHC staining system, the Oncogramme IVD for functional oncology testing, and the LymphoSign CE-IVD workflow for Non-Hodgkin Lymphoma subtyping.
The company generates revenue primarily through B2B e-commerce distribution at clinisciences.com, with product-specific unit pricing and zone-based shipping (e.g., USA $100 flat, European countries $39 with free shipping above approximately $520). Orders received before 16:00 are processed same day and shipped within two working days via express courier. CliniSciences supplements direct e-commerce with conference sponsorships (RBMP 2026, ICB CDT Chemical Biology 2026, Technician Partnership Conference 2026), an active webinar program, technical blog content, and email newsletters to drive demand within the scientific research community. The company has expanded its diagnostic capabilities through the 2024 acquisition of Oncomedics (Oncogramme IVD, with derogatory reimbursement from the French National Health Authority for colon cancer) and the acquisition of Genexpath (lymphoma and sarcoma IVD solutions), shifting the business mix incrementally toward proprietary clinical diagnostics alongside commodity reagent distribution. ISO 13485:2016 certification from IMQ underwrites the regulated product portfolio.
CliniSciences firmographics
Firmographics- Name
- CliniSciences
- Legal name
- CliniSciences LLC
- Website
- https://clinisciences.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CliniSciences is a privately held French-European distributor of reagents, instruments, and in vitro diagnostic products for immunology, cell biology, molecular biology, and oncology research, serving over 350,000 customers across 15 countries with a PhD-staffed scientific support team.
- Ownership category
- akta.pro rank
CliniSciences industry classification
Industry- Product category
- Life Science Reagents and Instruments Distribution
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Autoimmune, Allergy & Specialized Immunology Diagnostics (HLAHAAAK)
Keywords
Where CliniSciences is headquartered
LocationHeadquarters
- HQ city
- Nanterre
- HQ country
- France
- HQ region
- Europe
Offices4 records
Markets served
CliniSciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Product Distribution (Reagents and Equipment): CliniSciences generates revenue by distributing reagents, instruments, and equipment for scientific research and medical diagnosis. Products span immunology, cellular biology, molecular biology, and in vitro diagnostics. The company sells across Europe and North America through its e-commerce platform and operates an ISO 13485:2016 certified quality management system.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | E-commerce catalog with product-specific pricing and volume-based shipping |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels6 records
CliniSciences product offering
Product offeringCore offering
CliniSciences distributes reagents, instruments, and in vitro diagnostic products for immunology, cellular biology, and molecular biology research. The catalog spans FPLC columns, histological dyes, plant culture products, cell study kits, culture flasks, immunoassays, IHC detection kits, lectins, NGS products, radiochemical products, tetramers and monomers, plus proprietary offerings such as Oncogramme, LymphoSign CE-IVD, CellCover, NeoDye DNA dyes, and the PA-3600 automated IHC staining system. The company also offers custom laboratory services including cell toxicity tests, immunoassays, culture growth, and antibody production.
Product overview
CliniSciences is a European distributor of reagents and instruments for immunology, cellular biology, and molecular biology research. The product portfolio spans multiple categories including NeoDye DNA fluorescent dyes for gel electrophoresis, CellCover for cell stabilization, and a comprehensive range of FPLC columns, immunoassays, IHC kits, NGS products, and research consumables. In the diagnostic space, CliniSciences offers the Oncogramme® in vitro diagnostic device for personalized cancer treatment, the LymphoSign CE-IVD workflow for lymphoma classification, and the PA-3600 automated IHC staining system. The company also provides custom laboratory services and has expanded through acquisitions including Oncomedics (Oncogramme®) and Genexpath (lymphoma and sarcoma diagnostics).
Differentiator
Problem solved
Functional benefit
Brands
- Oncomedics: A biotechnology company acquired by CliniSciences Group, specializing in personalized cancer treatments and in vitro diagnostic medical devices, particularly the Oncogramme® for determining tumor sensitivity to anti-tumoral agents
- Genexpath
Products and services
- NeoDye DNA Fluorescent Dyes A range of fluorescent dyes (NeoDye DNA Green, NeoDye DNA Red, NeoDye DNA Blue, NeoDye DNA Orange) for DNA visualization in agarose gel electrophoresis. Non-toxic alternative to ethidium bromide, compatible with standard molecular biology workflows and UV/blue light detection.
- CellCover Non-toxic, one-step stabilization reagent that protects DNA, RNA, and proteins simultaneously in human and animal cells, solid tissues, and cultured cells for several days without freezing. Cells maintain near in vivo morphology without chemical crosslinking, enabling direct RNA isolation and downstream applications including flow cytometry, NGS, and single-cell RNA sequencing.
- Oncogramme In vitro diagnostic medical device that provides oncologists with decision-making support to identify the most effective treatment combinations for cancer patients. Involves culturing patient tumor cells and analyzing their mortality in response to different therapeutic molecules. First targeted indication is colon cancer, with expansion planned to breast and ovarian cancer. Obtained derogatory reimbursement from the French National Health Authority.
- PA-3600 Automated IHC System Fully automated immunohistochemistry (IHC) staining system designed for anatomopathology and molecular diagnostics. Based on antigen-antibody specific binding with chromogenic reagents, enabling IHC, ISH, and FISH applications with precision, efficiency, and reproducibility.
- LymphoSign CE-IVD CE-IVD marked diagnostic workflow enabling classification of over 80 subtypes of Non-Hodgkin Lymphoma through RT-MLPSeq analysis of more than 130 genetic markers. 4-step workflow from RNA to result, compatible with FFPE samples and Illumina sequencers, supported by AI-based RT-MIS software referencing over 3,000 tumor profiles.
- CliniSciences Research Reagents and Instruments Catalog Comprehensive catalog of research reagents and instruments for immunology, cellular biology, and molecular biology, including FPLC columns, special histological dyes, plant culture products, cell study kits, culture flasks, immunoassays, IHC detection kits, lectins, NGS products, radiochemical products, and tetramers/monomers. Sold across Europe and North America through the e-commerce platform.
- CliniSciences Custom Laboratory Services Custom laboratory services for research and diagnostic applications, including cell toxicity tests, immunoassays, culture growth, and antibody production. Supports laboratories requiring bespoke assay development and execution.
- Genexpath Diagnostic Solutions In vitro diagnostic solutions for lymphomas and sarcomas. Acquired by CliniSciences Group to strengthen its leadership in molecular biology and hemato-oncology diagnostics.
Quantifiable outcome
- Supports over 350,000 customers daily through 100 employees in 15 countries
- +2 more outcomes
Companies that use CliniSciences
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles1 record
CliniSciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
CliniSciences partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- OncomedicscoreCliniSciences acquired Oncomedics, a French biotechnology company specializing in the personalization of cancer treatments. Oncomedics developed the Oncogramme, an in vitro diagnostic medical device that provides oncologists with decision support to identify the most effective treatment combinations. First indication is colon cancer with expansion to breast and ovarian cancer. Oncomedics was founded in 2006 by Christophe Lautrette and Stephanie Giraud and has its own laboratory and production unit in Limoges, France. The company obtained derogatory reimbursement from the French National Health Authority for its Oncogramme test.
- GenexpathcoreCliniSciences strengthened its leadership in molecular biology and hemato-oncology with the strategic acquisition of Genexpath, a specialist in in vitro diagnostic solutions for lymphomas and sarcomas. This acquisition reinforces CliniSciences' diagnostic portfolio in oncology.
- NEOSETACminorNEOSETAC is a European networking project in which CliniSciences participates. Within NEOSETAC, CliniSciences works primarily in WP2 (Targeting of nanosystems), specifically in T2.1 (Antibody Selection) and T2.2 (Antibody Production). The focus is on training researchers in antibody production against breast cancer cell biomarkers and providing technical support for associating these antibodies with nanoparticles. REDINN, another company, visited CliniSciences as a NEOSETAC partner at the UAB Campus in Bellaterra.
- PSL AllianceminorCliniSciences joined the PSL Alliance, a dynamic global networking group for the IVD and RUO reagents industry, connecting with other industry players to strengthen its market presence.
- French Health Care AssociationminorCliniSciences joined the French Health Care Association as a member, providing a diversified and high-quality network to meet international markets with innovative French solutions.
- Angels SanteminorCliniSciences joined Angels Sante as Associate Corporate Member. Angels Sante is Europe's leading network of healthcare business angels, at the heart of healthcare start-ups, supporting CliniSciences' commitment to investing in scientific innovation.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
CliniSciences competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific: Global life-sciences distributor and manufacturer offering reagents, instruments, and diagnostics across immunology, cell biology, and molecular biology. Comparable as the dominant broad-line incumbent competing for the same research and IVD customers CliniSciences serves.
- Merck KGaA (MilliporeSigma Life Science): Supplies reagents, lab instruments, and diagnostic solutions through the Sigma-Aldrich and MilliporeSigma brands. Overlaps directly with CliniSciences' catalog across immunology, cell biology, and molecular biology, and competes for academic and pharma research accounts.
- Revvity (formerly PerkinElmer): Offers reagents, automated IHC/ISH systems, and diagnostics solutions across life sciences and applied markets. Comparable to CliniSciences in automated pathology (PA-3600) and oncology diagnostics.
- Eurofins Scientific: European-headquartered provider of laboratory testing services and life-science products across pharma, food, and clinical diagnostics. Overlaps with CliniSciences on European distribution reach and diagnostic service offerings.
Direct peers
- Bio-Techne: Develops and manufactures purified proteins, antibodies, immunoassays, and diagnostics reagents for life-science research and clinical diagnostics. Comparable as a specialty reagent and IVD player competing in similar research and oncology workflows.
- QIAGEN: Provides molecular biology reagents, sample-preparation technologies, and IVD assays including oncology and hematology diagnostics. Directly comparable to CliniSciences on the molecular biology / IVD axis, especially LymphoSign-type lymphoma workflows.
- Abcam: Specializes in antibody reagents and immunoassay tools for life-science research, including oncology and immunology. Competes with CliniSciences' immunoassays, IHC detection kits, and antibody offerings.
- BioLegend: Manufactures antibodies, immunoassays, and cell biology reagents for academic and clinical research. Comparable specialty reagent vendor competing for immunology and cell biology customers in CliniSciences' segment.
- Cell Signaling Technology: Specializes in antibodies and reagent kits for cell signaling, cancer research, and IHC applications. Comparable to CliniSciences in IHC detection kits and oncology research reagents.
- Santa Cruz Biotechnology: Supplies research antibodies, biochemicals, and lab reagents for life-science research including cancer and immunology applications. Comparable specialty reagent vendor competing in similar research reagent categories.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
CliniSciences social profiles
Digital presenceCliniSciences compliance and trust
Trust signalCompliance1 record
CliniSciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
CliniSciences leadership team
Management profileNumber of profiles
Profiles1 record
CliniSciences subsidiaries and ownership
Company hierarchySubsidiaries2 records
CliniSciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CliniSciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CliniSciences
What does CliniSciences do?
CliniSciences distributes reagents, instruments, and in vitro diagnostic products for immunology, cellular biology, and molecular biology research. The catalog spans FPLC columns, histological dyes, plant culture products, cell study kits, culture flasks, immunoassays, IHC detection kits, lectins, NGS products, radiochemical products, tetramers and monomers, plus proprietary offerings such as Oncogramme, LymphoSign CE-IVD, CellCover, NeoDye DNA dyes, and the PA-3600 automated IHC staining system. The company also offers custom laboratory services including cell toxicity tests, immunoassays, culture growth, and antibody production.
Is CliniSciences a public or private company?
CliniSciences is a private company. It is classified as unknown and is currently operating.
When was CliniSciences founded?
CliniSciences was founded in -1. It employs 11 to 50 people.
Where is CliniSciences based?
CliniSciences is headquartered in Nanterre, France, in the Europe region.
How does CliniSciences make money?
One revenue line is on record: product Distribution (Reagents and Equipment).
Who are CliniSciences's main competitors?
Broad incumbents on record are Thermo Fisher Scientific, Merck KGaA (MilliporeSigma Life Science), Revvity (formerly PerkinElmer) and Eurofins Scientific. Direct peers are Bio-Techne, QIAGEN, Abcam, BioLegend, Cell Signaling Technology and Santa Cruz Biotechnology.
Does CliniSciences have an API?
No public API is recorded for CliniSciences.
What industry is CliniSciences in?
CliniSciences's product category is Life Science Reagents and Instruments Distribution. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.